Several new drugs for the treatment of three types of cancer have been approved for inclusion in the National Health Insurance (NHI) program, which is expected to reduce the financial burden on some 1,000 patients per year and increase their life expectancy, Taiwan's government said Tuesday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan adjusts school calendar to ensure uninterrupted winter break
06/25/2025 03:00 PM - Society
Taiwan's allies showcase coffee, chili sauce, beef at Taipei Food Show
06/25/2025 02:44 PM - Business
Taipei food fair opens, attracting record 1,700 exhibitors
06/25/2025 02:32 PM - Business
Taiwan shares close up 1.09%
06/25/2025 01:55 PM - Society
Environment ministry to launch PM0.1 monitoring trials in 2026
06/25/2025 01:18 PM